Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease
Pakistan Journal of Medical Sciences. 2016; 32 (6): 1396-1401
en Inglés
| IMEMR
| ID: emr-184964
ABSTRACT
Objective:
To determine the effect of Vildagliptin in non-alcoholic, fatty liver disease patients with dyslipidemia
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
Pak. J. Med. Sci.
Año:
2016
Similares
MEDLINE
...
LILACS
LIS